We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Local NHS diabetic eye screening (DES) providers must use these letters to invite people for screening and inform them of their results.
Latest updates on SARS-CoV-2 variants detected in the UK.
THE UK Commission on Covid Commemoration’s final report on how the Covid pandemic should be remembered across the UK has been published
The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and effectiveness.
UKHSA's flagship SIREN study is entering a new phase working with NHS sites to provide surveillance of respiratory infections in healthcare workers.
Government invests £200 million of new funding to boost NHS resilience and ensure patients receive the care they need this winter.
The Downing Street session will see NHS leaders come together to discuss actions to improve care for patients and ease pressures on the health service.
The vaccine was approved after it was found to meet the UK regulator's standards of safety, quality and effectiveness
Precautionary measure taken to protect those most vulnerable from illness during winter following the identification of COVID-19 variant BA.2.86.
The new vaccine from HIPRA Human Health has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
UK statement on Paragraph 8 of MC12 Decision on the TRIPS Agreement adopted on 17 June 2022. This statement was delivered at the WTO in Geneva on 14 June 2023.
A letter from the Cabinet Office to the Covid-19 Inquiry
A Statement of Facts and Grounds
A witness statement from the Cabinet Office to the Covid-19 Inquiry
Information for healthcare professionals and the public about the COVID-19 Vaccine SKYCovion
The new COVID-19 vaccine from SK Chemicals, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The COVID-19 vaccine from Moderna has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
The offer of a first or second dose of COVID-19 vaccine will end on 30 June 2023 for most people.
Notification to GPs and NHS England that they should share information to support efforts against coronavirus (COVID-19).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.